Literature DB >> 28427735

Comparison of Frequency and Characteristics of Patients With Atrial Fibrillation Having Ablation With Versus Without Coronary Narrowing (≥50%) by Angiography.

Toshiro Tomomatsu1, Itsuro Morishima2, Kenji Okumura3, Hideyuki Tsuboi1, Yasuhiro Morita1, Kensuke Takagi1, Ruka Yoshida1, Hiroaki Nagai1, Yoshihiro Ikai1, Naoki Shibata1, Kazuhito Tsuzuki1, Takahito Sone1, Toyoaki Murohara4.   

Abstract

Atrial fibrillation (AF) shares background comorbidities with coronary artery disease (CAD), including hypertension and diabetes mellitus. The aim of the study is to evaluate the prevalence, risk factors, and prognostic significance of CAD among patients who underwent catheter ablation for AF. In 544 consecutive registered patients who underwent catheter ablation for AF (CHADS2 score 1.2 ± 1.1, paroxysmal AF 57%), quantitative coronary angiography was used to detect CAD, defined as luminal narrowing of ≥50% in diameter. Univariate and multiple logistic regression analyses were applied to evaluate the risk factors of CAD. Subsequent clinical events up to 1 year were obtained in all the patients. CAD was found in 70 patients (13%). The factors associated with the presence of CAD in AF patients who underwent catheter ablation were similar to traditional coronary risk factors such as hypertension and diabetes mellitus. AF patients with CAD had a higher CHADS2 score than those without CAD (1.5 ± 1.1 vs 1.1 ± 1.0, p = 0.009). Hence, a CHADS2 score ≥1 may be an alternative risk factor to predict CAD. Previous coronary revascularization (14% with CAD vs 6% without CAD) and paroxysmal AF (69% vs 55%) were also associated with CAD. During follow-up, patients with CAD experienced acute coronary syndrome (n = 2) and coronary revascularization (n = 18); no such events were recorded in those without CAD. In addition to traditional risk factors, CHADS2 score, previous revascularization, and paroxysmal AF may be new risk factors for CAD in AF patients.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28427735     DOI: 10.1016/j.amjcard.2017.02.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation.

Authors:  Serkan Cay; Meryem Kara; Firat Ozcan; Ozcan Ozeke; Tolga Aksu; Dursun Aras; Serkan Topaloglu
Journal:  J Interv Card Electrophysiol       Date:  2022-04-02       Impact factor: 1.900

2.  Evaluation of Coronary Artery Disease in Patients with Atrial Fibrillation by Cardiac Computed Tomography for Catheter Ablation: CADAF-CT Trial 2.

Authors:  Yoshibumi Antoku; Masao Takemoto; Takahiro Mito; Akihiro Masumoto; Masatsugu Nozoe; Atsushi Tanaka; Yusuke Yamamoto; Takafumi Ueno; Takuya Tsuchihashi
Journal:  Intern Med       Date:  2020-07-21       Impact factor: 1.271

3.  Evaluation of coronary artery disease in patients with atrial fibrillation by cardiac computed tomography for catheter ablation: CADAF-CT trial.

Authors:  Takahiro Mito; Masao Takemoto; Yoshibumi Antoku; Akihiro Masumoto; Masatsugu Nozoe; Satoko Kinoshita; Atsushi Tanaka; Yusuke Yamamoto; Takafumi Ueno; Takuya Tsuchihashi
Journal:  Heart Vessels       Date:  2020-03-05       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.